Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity

Documenti analoghi

• Stimulation of bone formation in cortical bone of the mice treated with a novel bone anabolic peptide with osteoclastogenesis inhibitory activity
  di: Furuya, Yuriko, et al.
  Pubblicazione: (2012)
• From discovery of RANKL to clinical application of anti-human RANKL antibody
  di: Yasuda, Hisataka, et al.
  Pubblicazione: (2012)
• Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis
  di: Ozaki, Yuki, et al.
  Pubblicazione: (2017)
• Increased Bone Mass in Mice after Single Injection of Anti-receptor Activator of Nuclear Factor-κB Ligand-neutralizing Antibody: EVIDENCE FOR BONE ANABOLIC EFFECT OF PARATHYROID HORMONE IN MICE WITH FEW OSTEOCLASTS
  di: Furuya, Yuriko, et al.
  Pubblicazione: (2011)
• Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
  di: Yasuda, Hisataka, et al.
  Pubblicazione: (1998)